EcoDrugPlus

Potassium Voltage-Gated Channel Subfamily Q Member 2

Ensembl ID : ENSPEMG00000000964
Gene Symbol: KCNQ2
3 Cross references
248 Possible Orthologues:

Potassium Voltage-Gated Channel, Subfamily Q, Member 3

Ensembl ID : ENSPEMG00000011043
Gene Symbol: KCNQ3
1 Cross references
191 Possible Orthologues:

Potassium Voltage-Gated Channel, Subfamily Q, Member 5

Ensembl ID : ENSPEMG00000017858
Gene Symbol: KCNQ5
1 Cross references
278 Possible Orthologues:

Presenilin 1

Ensembl ID : ENSPEMG00000006667
Gene Symbol: PSEN1
3 Cross references
200 Possible Orthologues:

Presenilin 2

Ensembl ID : ENSPEMG00000006562
Gene Symbol: PSEN2
3 Cross references
205 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSPEMG00000011498
Gene Symbol: PSENEN
3 Cross references
183 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSPEMG00000020732
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSPEMG00000001726
Gene Symbol: PTGDR2
1 Cross references
206 Possible Orthologues:

Prostaglandin D2 Receptor-Like

Ensembl ID : ENSPEMG00000010045
Gene Symbol: LOC102923272
3 Cross references
118 Possible Orthologues:

Prostaglandin E Receptor 1

Ensembl ID : ENSPEMG00000027389
Gene Symbol: PTGER1
3 Cross references
235 Possible Orthologues:

Prostaglandin E Receptor 2 (Subtype Ep2)

Ensembl ID : ENSPEMG00000004119
Gene Symbol: PTGER2
1 Cross references
241 Possible Orthologues:

Prostaglandin E Receptor 3 (Subtype Ep3)

Ensembl ID : ENSPEMG00000009210
Gene Symbol: PTGER3
1 Cross references
194 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).